82474 Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices 

eRegistration link. Select the eFiling 

link to log on and submit the 

intervention or protests. 

Persons unable to file electronically 

may mail similar pleadings to the 

Federal Energy Regulatory Commission, 

888 First Street NE, Washington, DC 

20426. Hand delivered submissions in 

docketed proceedings should be 

delivered to Health and Human 

Services, 12225 Wilkins Avenue, 

Rockville, Maryland 20852. 

In addition to publishing the full text 

of this document in the Federal 

Register, the Commission provides all 

interested persons an opportunity to 

view and/or print the contents of this 

document via the internet through the 

Commission’s Home Page (http://

ferc.gov) using the ‘‘eLibrary’’ link. 

Enter the docket number excluding the 

last three digits in the docket number 

field to access the document. At this 

time, the Commission has suspended 

access to the Commission’s Public 

Reference Room, due to the 

proclamation declaring a National 

Emergency concerning the Novel 

Coronavirus Disease (COVID–19), issued 

by the President on March 13, 2020. For 

assistance, contact the Federal Energy 

Regulatory Commission at 

FERCOnlineSupport@ferc.gov or call 

toll-free, (886) 208–3676 or TYY, (202) 

502–8659. 

Dated: December 14, 2020. 

Kimberly D. Bose, 

Secretary. 

[FR Doc. 2020–27932 Filed 12–17–20; 8:45 am] 

BILLING CODE 6717–01–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[ER–FRL–9054–4] 

Environmental Impact Statements; 

Notice of Availability 

Responsible Agency: Office of Federal 

Activities, General Information 202– 

564–5632 or https://www.epa.gov/nepa. 

Weekly receipt of Environmental Impact 

Statements (EIS) 

Filed December 7, 2020 10 a.m. EST 

Through December 14, 2020 10 a.m. 

EST 

Pursuant to 40 CFR 1506.9. 

Notice: Section 309(a) of the Clean Air 

Act requires that EPA make public its 

comments on EISs issued by other 

Federal agencies. EPA’s comment letters 

on EISs are available at: https://

cdxnodengn.epa.gov/cdx-enepa-public/ 

action/eis/search. 

EIS No. 20200260, Final Supplement, 

BR, CA, B.F. Sisk Dam Raise and 

Reservoir Expansion Project, Review 

Period Ends: 01/19/2021, Contact: 

Casandra Arthur 530–892–6202. 

EIS No. 20200261, Draft Supplement, 

USACE, FL, Port Everglades Harbor, 

Broward County, Florida, Comment 

Period Ends: 02/01/2021, Contact: 

Angela Dunn 904–232–2336. 

Amended Notice 

EIS No. 20200210, Draft, STB, UT, Uinta 

Basin Railway, Comment Period Ends: 

01/28/2021, Contact: Joshua Wayland 

202–245–0330. 

Revision to FR Notice Published 10/30/ 

2020; Extending the Comment Period 

from 12/14/2020 to 01/28/2021. 

EIS No. 20200242, Draft, USACE, VA, 

Surry To Skiffes Creek to Whealton 

Transmission Project, Comment 

Period Ends: 02/10/2021, Contact: 

Randy Steffey 757–201–7579. 

Revision to FR Notice Published 11/27/ 

2020; Extending the Comment Period 

from 01/11/2021 to 02/10/2021. 

Dated: December 14, 2020. 

Cindy S. Barger, 

Director, NEPA Compliance Division, Office 

of Federal Activities. 

[FR Doc. 2020–27888 Filed 12–17–20; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2019–0502; FRL–10017– 

44] 

Perchloroethylene (PCE); Final Toxic 

Substances Control Act (TSCA) Risk 

Evaluation; Notice of Availability 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Environmental Protection 

Agency (EPA) is announcing the 

availability of the final Toxic 

Substances Control Act (TSCA) risk 

evaluation of perchloroethylene (PCE). 

The purpose of conducting risk 

evaluations under TSCA is to determine 

whether a chemical substance presents 

an unreasonable risk of injury to health 

or the environment under the 

conditions of use, including an 

unreasonable risk to a relevant 

potentially exposed or susceptible 

subpopulation, without consideration of 

costs or other nonrisk factors. EPA has 

determined that specific conditions of 

use of PCE present an unreasonable risk 

of injury to health or the environment. 

For those conditions of use for which 

EPA has found an unreasonable risk, 

EPA must move to address that 

unreasonable risk through risk 

management measures enumerated in 

TSCA. EPA has also determined that 

specific conditions of use do not present 

unreasonable risk of injury to health or 

the environment. For those conditions 

of use for which EPA has found no 

unreasonable risk to health or the 

environment, the Agency’s 

determination is a final Agency action 

and is issued via order in the risk 

evaluation. 

ADDRESSES: The docket for this action, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2019–0502, is 

available online at http://

www.regulations.gov or in-person at the 

Office of Pollution Prevention and 

Toxics Docket (OPPT Docket), 

Environmental Protection Agency 

Docket Center (EPA/DC), West William 

Jefferson Clinton Bldg., Rm. 3334, 1301 

Constitution Ave. NW, Washington, DC. 

The Public Reading Room is open from 

8:30 a.m. to 4:30 p.m., Monday through 

Friday, excluding legal holidays. The 

telephone number for the Public 

Reading Room is (202) 566–1744, and 

the telephone number for the OPPT 

Docket is (202) 566–0280. 

Due to the public health concerns 

related to COVID–19, the EPA Docket 

Center (EPA/DC) and Reading Room is 

closed to visitors with limited 

exceptions. The staff continues to 

provide remote customer service via 

email, phone, and webform. For the 

latest status information on EPA/DC 

services and docket access, visit https:// 

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: For 

technical information contact: Yvette 

Selby-Mohamadu, Office of Pollution 

Prevention and Toxics, Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW, Washington, DC 20460–0001; 

telephone number: (202) 564–5245; 

email address: selby-mohamadu.yvette@

epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general. This action may be of 

interest to persons who are or may be 

interested in risk evaluations of 

chemical substances under TSCA, 15 

U.S.C. 2601 et seq. Since other entities 

may also be interested in this final risk 

evaluation, the EPA has not attempted 

to describe all the specific entities that 

may be affected by this action. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices 82475 

B. What is the Agency’s authority for 

taking this action? 

TSCA section 6, 15 U.S.C. 2605, 

requires EPA to conduct risk 

evaluations to ‘‘determine whether a 

chemical substance presents an 

unreasonable risk of injury to health or 

the environment, without consideration 

of costs or other nonrisk factors, 

including an unreasonable risk to a 

potentially exposed or susceptible 

subpopulation identified as relevant to 

the risk evaluation by the 

Administrator, under the conditions of 

use.’’ 15 U.S.C. 2605(b)(4)(A). TSCA 

sections 6(b)(4)(A) through (H) 

enumerate the deadlines and minimum 

requirements applicable to this process, 

including provisions that provide 

instruction on chemical substances that 

must undergo evaluation, the minimum 

components of a TSCA risk evaluation, 

and the timelines for public comment 

and completion of the risk evaluation. 

TSCA also requires that EPA operate in 

a manner that is consistent with the best 

available science, make decisions based 

on the weight of the scientific evidence 

and consider reasonably available 

information. 15 U.S.C. 2625(h), (i), and 

(k). TSCA section 6(i) directs that a 

determination of ‘‘no unreasonable risk’’ 

shall be issued by order and considered 

to be a final Agency action, while a 

determination of ‘‘unreasonable risk’’ is 

not considered to be a final Agency 

action. 15 U.S.C. 2605(i). 

The statute identifies the minimum 

components for all chemical substance 

risk evaluations. For each risk 

evaluation, EPA must publish a 

document that outlines the scope of the 

risk evaluation to be conducted, which 

includes the hazards, exposures, 

conditions of use, and the potentially 

exposed or susceptible subpopulations 

that EPA expects to consider. 15 U.S.C. 

2605(b)(4)(D). The statute further 

provides that each risk evaluation must 

also: (1) integrate and assess available 

information on hazards and exposures 

for the conditions of use of the chemical 

substance, including information that is 

relevant to specific risks of injury to 

health or the environment and 

information on relevant potentially 

exposed or susceptible subpopulations; 

(2) describe whether aggregate or 

sentinel exposures were considered and 

the basis for that consideration; (3) take 

into account, where relevant, the likely 

duration, intensity, frequency, and 

number of exposures under the 

conditions of use; and (4) describe the 

weight of the scientific evidence for the 

identified hazards and exposures. 15 

U.S.C. 2605(b)(4)(F)(i) through (ii) and 

(iv) through (v). Each risk evaluation 

must not consider costs or other nonrisk 

factors. 15 U.S.C. 2605(b)(4)(F)(iii). 

The statute requires that the risk 

evaluation process be completed within 

a specified timeframe and provide an 

opportunity for public comment on a 

draft risk evaluation prior to publishing 

a final risk evaluation. 15 U.S.C. 

2605(b)(4). 

Subsection 5.4.1 of the final risk 

evaluation for PCE constitutes the order 

required under TSCA section 6(i)(1), 

and the ‘‘no unreasonable risk’’ 

determinations in that subsection are 

considered to be a final Agency action 

effective on the date of issuance of the 

order. In conducting risk evaluations, 

‘‘EPA will determine whether the 

chemical substance presents an 

unreasonable risk of injury to health or 

the environment under each condition 

of use within the scope of the risk 

evaluation. . ..’’ 40 CFR 702.47. Under 

EPA’s implementing regulations, ‘‘[a] 

determination by EPA that the chemical 

substance, under one or more of the 

conditions of use within the scope of 

the risk evaluation, does not present an 

unreasonable risk of injury to health or 

the environment will be issued by order 

and considered to be a final Agency 

action, effective on the date of issuance 

of the order.’’ 40 CFR 702.49(d). For 

purposes of TSCA section 19(a)(1)(A), 

the date of issuance of the TSCA section 

6(i)(1) order for PCE shall be at 1:00 

p.m. Eastern time (standard or daylight, 

as appropriate) on the date that is two 

weeks after the date when this notice is 

published in the Federal Register, 

which is in accordance with 40 CFR 

23.5. 

C. What action is EPA taking? 

EPA is announcing the availability of 

the risk evaluation of the chemical 

substance identified in Unit II. In this 

risk evaluation EPA has made 

unreasonable risk determinations on 

some of the conditions of use within the 

scope of the risk evaluation for this 

chemical. For those conditions of use 

for which EPA has found an 

unreasonable risk of injury to health or 

the environment, EPA must initiate 

regulatory action to address those risks 

through risk management measures 

enumerated in 15 U.S.C. 2605(a). 

EPA also is announcing the 

availability of the information required 

to be provided publicly with each risk 

evaluation, which is available online at 

http://www.regulations.gov in the 

dockets identified. 40 CFR 702.51. 

Specifically, EPA has provided: 

• The scope document and problem 

formulation (in Docket ID No. EPA–HQ– 

OPPT–2016–0732); 

• Draft risk evaluation and final risk 

evaluation (in Docket ID No. EPA–HQ– 

OPPT–2019–0502); 

• All notices, determinations, 

findings, consent agreements, and 

orders (in Docket ID No. EPA–HQ– 

OPPT–2019–0502); 

• Any information required to be 

provided to the Agency under 15 U.S.C. 

2603 (in Docket ID No. EPA–HQ–OPPT– 

2016–0732 and Docket ID No. EPA–HQ– 

OPPT–2019–0502); 

• A nontechnical summary of the risk 

evaluation (in Docket ID No. EPA–HQ– 

OPPT–2019–0502); 

• A list of the studies, with the results 

of the studies, considered in carrying 

out each risk evaluation (Risk 

Evaluation for Perchloroethylene 

(Ethene, 1,1,2,2-Tetrachloro-)) in Docket 

ID No. EPA–HQ–OPPT–2019–0502); 

• The final peer review report, 

including the response to peer review 

and public comments received during 

peer review (in Docket ID No. EPA–HQ– 

OPPT–2019–0502); and 

• Response to public comments 

received on the draft scope and the draft 

risk evaluation (in Docket ID No. EPA– 

HQ–OPPT–2019–0502). 

II. TSCA Risk Evaluation 

A. What is EPA’s risk evaluation process 

for existing chemicals under TSCA? 

The risk evaluation process is the 

second step in EPA’s existing chemical 

process under TSCA, following 

prioritization and before risk 

management. As this chemical is one of 

the first ten chemical substances 

undergoing risk evaluation, the 

chemical substance was not required to 

go through prioritization (81 FR 91927, 

December 19, 2016) (FRL–9956–47). The 

purpose of conducting risk evaluations 

is to determine whether a chemical 

substance presents an unreasonable risk 

of injury to health or the environment 

under the conditions of use, including 

an unreasonable risk to a relevant 

potentially exposed or susceptible 

subpopulation. As part of this process, 

EPA must evaluate both hazard and 

exposure, not consider costs or other 

nonrisk factors, use reasonably available 

information and approaches in a 

manner that is consistent with the 

requirements in TSCA for the use of the 

best available science, and ensure 

decisions are based on the weight of the 

scientific evidence. 

The specific risk evaluation process 

that EPA has established by rule to 

implement the statutory process is set 

out in 40 CFR part 702 and summarized 

on EPA’s website at http://

www.epa.gov/assessing-and-managingchemicals-under-tsca/risk-evaluationsVerDate Sep<11>2014 22:22 Dec 17, 2020 Jkt 253001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\18DEN1.SGM 18DEN1

khammond on DSKJM1Z7X2PROD with NOTICES
82476 Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices 

existing-chemicals-under-tsca. As 

explained in the preamble to EPA’s final 

rule on procedures for risk evaluation 

(82 FR 33726, July 20, 2017) (FRL– 

9964–38), the specific regulatory 

process set out in 40 CFR part 702, 

subpart B will be followed for the first 

ten chemical substances undergoing risk 

evaluation to the maximum extent 

practicable. 

Prior to the publication of this final 

risk evaluation, a draft risk evaluation 

was subject to peer review and public 

comment. EPA reviewed the peer 

review report from the Science Advisory 

Committee on Chemicals (SACC) and 

public comments and has supplemented 

the risk evaluation in response to these 

comments as appropriate. The public 

comments and peer review report are in 

Docket EPA–HQ–OPPT–2019–0502 at 

www.regulations.gov. Prior to the 

publication of the draft risk evaluation, 

EPA made available the scope and 

problem formulation, and solicited 

public input on uses and exposure. 

EPA’s documents and the public 

comments are in Docket EPA–HQ– 

OPPT–2019–0502. Additionally, 

information about the scope, problem 

formulation, and draft risk evaluation 

phases of the TSCA risk evaluation for 

this chemical is available at https://

www.epa.gov/assessing-and-managingchemicals-under-tsca/risk-evaluationperchloroethylene. 

B. What is Perchloroethylene? 

Perchloroethylene is currently 

manufactured, processed, distributed, 

used, and disposed of as part of a wide 

range of industrial, commercial, and 

consumer conditions of use, including 

production of fluorinated compounds, 

and as a solvent in dry cleaning and 

vapor degreasing. Consumer and 

commercial products that contain 

perchloroethylene include adhesives 

(arts and crafts, as well as light repairs), 

aerosol degreasing, brake cleaners, 

aerosol lubricants, sealants, stone 

polish, stainless steel polish and other 

cleaners used for wiping surfaces. The 

yearly aggregate production volume for 

perchloroethylene ranged from 388 to 

324 million pounds between 2012 and 

2015 according to CDR data. 

Authority: 15 U.S.C. 2601 et seq. 

Andrew Wheeler, 

Administrator. 

[FR Doc. 2020–27880 Filed 12–17–20; 8:45 am] 

BILLING CODE 6560–50–P 

FEDERAL COMMUNICATIONS 

COMMISSION 

[FRS 17305] 

Federal Advisory Committee Act; 

Technological Advisory Council 

AGENCY: Federal Communications 

Commission. 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice advises interested persons that 

the Federal Communications 

Commission’s (FCC) Technological 

Advisory Council will hold a meeting 

on Thursday January 14, 2021 via 

conference call and available to the 

public via the internet at http://

www.fcc.gov/live, from 10:00 a.m. to 

12:30 p.m. 

DATES: Thursday January 14, 2021. 

ADDRESSES: Federal Communications 

Commission, 45 L Street NE, 

Washington, DC 20554. 

FOR FURTHER INFORMATION CONTACT: 

Michael Ha, Deputy Chief, Policy and 

Rules Division 202–418–2099; 

michael.ha@fcc.gov. 

SUPPLEMENTARY INFORMATION: At the 

January 14th meeting, the TAC will 

consider and vote on a white paper 

prepared by the Artificial Intelligence 

working group and recommendations 

from its four working groups: 5G/IOT/ 

V–RAN, Future of Unlicensed 

Operations, Artificial Intelligence, and 

5G Radio Access Network Technology. 

This agenda may be modified at the 

discretion of the TAC Chair and the 

Designated Federal Officer (DFO). 

Meetings are broadcast live with open 

captioning over the internet from the 

FCC Live web page at http://

www.fcc.gov/live/. The public may 

submit written comments before the 

meeting to Michael Ha, the FCC’s 

Designated Federal Officer for 

Technological Advisory Council by 

email: michael.ha@fcc.gov or U.S. Postal 

Service Mail (Michael Ha, Federal 

Communications Commission, 45 L 

Street NE, Washington, DC 20554). 

Open captioning will be provided for 

this event. Other reasonable 

accommodations for people with 

disabilities are available upon request. 

Requests for such accommodations 

should be submitted via email to 

fcc504@fcc.gov or by calling the Office 

of Engineering and Technology at 202– 

418–2470 (voice), (202) 418–1944 (fax). 

Such requests should include a detailed 

description of the accommodation 

needed. In addition, please include your 

contact information. Please allow at 

least five days advance notice; last 

minute requests will be accepted but 

may not be possible to fill. 

Federal Communications Commission. 

Ronald T. Repasi, 

Acting Chief, Office of Engineering and 

Technology. 

[FR Doc. 2020–27832 Filed 12–17–20; 8:45 am] 

BILLING CODE 6712–01–P 

FEDERAL FINANCIAL INSTITUTIONS 

EXAMINATION COUNCIL 

[Docket No. AS20–14] 

Agency Information Collection 

Activities; Renewal of an Approved 

Information Collection: Reporting 

information for the AMC Registry 

AGENCY: Appraisal Subcommittee of the 

Federal Financial Institutions 

Examination Council (ASC) 

ACTION: Notice and request for 

comments. 

SUMMARY: In accordance with the 

Paperwork Reduction Act of 1995, the 

ASC invites public comments on our 

intention to request the Office of 

Management and Budget (OMB) 

approval to renew an information 

collection request entitled ‘‘Reporting 

information for the AMC Registry.’’ 

DATES: Written comments must be 

received on or before February 16, 2021 

to be assured of consideration. 

ADDRESSES: Commenters are encouraged 

to submit comments by the Federal 

eRulemaking Portal or email, if possible. 

You may submit comments, identified 

by Docket Number AS20–14, by any of 

the following methods: 

• Federal eRulemaking Portal: 

https://www.Regulations.gov. Follow 

the instructions for submitting 

comments. Click on the ‘‘Help’’ tab on 

the Regulations.gov home page to get 

information on using Regulations.gov, 

including instructions for submitting 

public comments. 

• E-Mail: webmaster@asc.gov. Include 

the docket number in the subject line of 

the message. 

• Fax: (202) 289–4101. Include the 

docket number of fax cover sheet. 

• Mail: Address to Appraisal 

Subcommittee, Attn: Lori Schuster, 

Management and Program Analyst, 1325 

G Street NW, Suite 500, Washington, DC 

20005. 

• Hand Delivery/Courier: 1325 G 

Street NW, Suite 500, Washington, DC 

20005. 

In general, the ASC will enter all 

comments received into the docket and 

publish those comments on the 

Regulations.gov website without 

change, including any business or 


khammond on DSKJM1Z7X2PROD with NOTICES